|Slideshows|June 1, 2017

5 Key Issues About Comorbidity in Geriatric Bipolar Disorder

Author(s)Soham Rej, MD, MSc, Rayan k. Al Jurdi, MD, Martha Sajatovic, MD

Clinicians need to consider and manage multiple medical and cognitive comorbidities when working with the elderly population. This slideshow provides an overview of key points relevant to geriatric bipolar disorder as it relates to comorbidity.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Subscribe

Related Content

Brain Trust: Anita H. Clayton, MD, on Diagnosing and Treating Sexual Dysfunction

ByJoseph F. Goldberg, MD,Anita H. Clayton, MD

September 2nd 2026

The 5 Faces of Bipolar Depression: A Case-Based Reflection

ByHameed Younis, MD

August 26th 2026

Benzodiazepines in Older Adults: Alzheimer Risk, Memory, and Beers Criteria

ByJoseph F. Goldberg, MD,Carl Salzman, MD

August 26th 2026

Migraine and Psychiatric Comorbidities

ByHoracio A. Capote, MD

August 24th 2026

Skin and Psych: Using Habit Loop Science to Interrupt the Itch-Scratch Cycle, With Judson Brewer, MD, PhD

ByPatricia M. Delgado, DNP, AGPCNP, DCNP, PMHNP,Judson A. Brewer, MD, PhD

August 24th 2026

Latest CME

In-Person Event

Jersey City Psychiatry

October 2-3, 2026

Register now!

Video

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

John Koo, MD; T.J. Chao, MPAS, PA-C

Video

Expert Illustrations & Commentary: Visualizing the Role of Novel Muscarinic Agents in the Management of Schizophrenia

Ilan Melnick, MD; Linda Collado, MD, DABPN, FAPA; Maria Collado, MD, FAPA

Video

Expert Illustrations & Commentary: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Juan D. Oms, MD, FAPA; Linda Collado, MD, DABPN, FAPA; Ginger Shupe, MD

Video

(CPE Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Video

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

Video

Cases and Conversations™: Optimizing Administration of Treatment for Patients with Schizophrenia

Gus Alva, MD, DFAPA; Erin Crown, MHS, PA-C

5 Key Issues About Comorbidity in Geriatric Bipolar Disorder

Related Content

Brain Trust: Anita H. Clayton, MD, on Diagnosing and Treating Sexual Dysfunction

The 5 Faces of Bipolar Depression: A Case-Based Reflection

Benzodiazepines in Older Adults: Alzheimer Risk, Memory, and Beers Criteria

Migraine and Psychiatric Comorbidities

Skin and Psych: Using Habit Loop Science to Interrupt the Itch-Scratch Cycle, With Judson Brewer, MD, PhD

Latest CME

Jersey City Psychiatry

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

Expert Illustrations & Commentary: Visualizing the Role of Novel Muscarinic Agents in the Management of Schizophrenia

Expert Illustrations & Commentary: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

(CPE Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Cases and Conversations™: Optimizing Administration of Treatment for Patients with Schizophrenia

Trending on Psychiatric Times

Repurposing Dopamine Agonist Pramipexole for Disabling Anhedonia

Brain Trust: Anita H. Clayton, MD, on Diagnosing and Treating Sexual Dysfunction

GLP-1 Receptor Agonists Linked to Lower Mortality, Cardiovascular Events in Serious Mental Illness

When Treatment-Resistant Depression Means Mismatched: Rethinking Difficult-to-Treat Depression

The Year So Far in GLP-1s: What Psychiatric Clinicians Need to Know